• circ0043898 and KRAS Regulate Cancer Stemness in Esophageal

  2026-07-02

  Wang et al. (2025) reveal that overexpression of circ0043898 suppresses stemness properties in esophageal cancer cells, while concurrent KRAS overexpression counteracts this effect. This mechanistic insight identifies the circ0043898–KRAS axis as a potential therapeutic target for modulating cancer stem cell phenotypes in esophageal cancer.

• saRNA Vaccines Enhance Influenza Immunity via RNA Modificati

  2026-07-02

  The referenced study demonstrates that self-amplifying RNA (saRNA) vaccines significantly improve immunogenicity and dose-sparing efficacy against seasonal influenza, especially influenza B, compared to conventional mRNA platforms. These findings highlight how RNA modification strategies, including nucleoside modifications, address subtype limitations and inform next-generation vaccine design.

• G418 Sulfate: Precision Selection & Antiviral Workflows with

  2026-07-01

  G418 Sulfate (Geneticin) empowers genetic engineers and virologists with robust, reproducible cell selection and advanced Dengue virus inhibition. Explore validated protocols, troubleshooting tips, and evidence-based innovations that set APExBIO’s G-418 apart for both routine and cutting-edge cell culture applications.

• PPT1 and ZDHHC7 Regulation of SPRY4 Palmitoylation in Cispla

  2026-07-01

  This study reveals how PPT1 and ZDHHC7 dynamically regulate SPRY4 palmitoylation, controlling MAPK signaling and contributing to cisplatin resistance in osteosarcoma. Inhibiting PPT1 with GNS561 restores cisplatin sensitivity, offering a new therapeutic avenue for drug-resistant tumors.

• MLN2238: Precision Proteasome β5 Subunit Inhibitor for Oncol

  2026-06-30

  MLN2238 is a potent, reversible proteasome β5 subunit inhibitor with nanomolar activity and established utility in multiple myeloma and lymphoma research. APExBIO’s MLN2238 (SKU A4008) demonstrates efficacy even in bortezomib-resistant models and enables mechanistic studies of apoptosis and proteostasis.

• PFHxS-Induced Hepatotoxicity via PPARα in Zebrafish: Mechani

  2026-06-30

  This study demonstrates that environmentally relevant concentrations of perfluorohexanesulfonic acid (PFHxS), a persistent short-chain PFAS, induce hepatotoxicity in larval zebrafish through activation of the PPARα signaling pathway. The findings clarify the mechanistic basis of PFHxS toxicity and highlight the utility of PPARα antagonists for investigating environmental impacts on liver function and metabolic homeostasis.

• N6-Methyl-dATP: Precision Epigenetic Probe for DNA Fidelity

  2026-06-29

  N6-Methyl-dATP uniquely enables targeted analysis of DNA replication fidelity and methylation-driven genomic stability in both disease and drug discovery workflows. This advanced nucleotide analog, supplied by APExBIO, empowers troubleshooting and optimization in epigenetic research, especially where high selectivity and reproducibility are paramount.

• Optimizing O-GlcNAcylation Research with OSMI-1 (SKU B7923)

  2026-06-29

  This article addresses key bench challenges in O-GlcNAcylation research and demonstrates how OSMI-1 (SKU B7923), a cell-permeable O-GlcNAc transferase inhibitor from APExBIO, provides reproducible, quantitative control for cellular and in vivo assays. Scenario-driven Q&A blocks deliver actionable, data-backed guidance for cell viability, cytotoxicity, and protein modification studies.

• Prednisone as a Precision Tool: Next-Gen Immunology & Neurod

  2026-06-28

  Explore how Prednisone, a synthetic corticosteroid, advances precision modeling of immunosuppression and neurodegeneration in laboratory research. This article offers a deep dive into its unique mechanistic actions and best practices for high-fidelity in vitro and in vivo studies.

• Lithium-Enhanced Exosomal Wnt10a Secretion Drives Osteogenes

  2026-06-27

  This study uncovers how lithium augments bone mesenchymal stem cell (BMSC) osteogenesis by promoting exosomal Wnt10a secretion and activating Wnt/β-catenin signaling. The mechanistic insights reveal Rab11a-mediated trafficking as a critical step, offering new translational avenues for improving bone regeneration strategies.

• O6-Benzylguanine: Precision MGMT Inhibitor for Chemotherapy

  2026-06-26

  O6-Benzylguanine empowers researchers to overcome DNA repair-mediated chemotherapy resistance through targeted MGMT inhibition. This article spotlights hands-on workflows, protocol optimization, and actionable troubleshooting rooted in the latest translational findings.

• Mycophenolic Acid: Dehydrogenase Inhibitor in Immune Assays

  2026-06-26

  Mycophenolic acid stands out as a research-grade dehydrogenase inhibitor enabling reproducible modulation of immune cell metabolism in whole-blood stimulation assays. By standardizing metabolic intervention protocols, researchers can precisely interrogate cytokine responses and immune regulation. APExBIO ensures high-quality supply for reliable, advanced immunometabolism exploration.

• ONX-0914 (PR-957): Precision Immunoproteasome Inhibition in

  2026-06-25

  ONX-0914 (PR-957) delivers unmatched selectivity for immunoproteasome targeting, empowering researchers to dissect cytokine-driven pathology in autoimmune and inflammatory models. Explore advanced protocols and troubleshooting strategies that maximize its impact, with novel insights from recent studies illuminating new avenues for immune modulation.

• Temozolomide: Small-Molecule Alkylating Agent for Glioma Mod

  2026-06-25

  Temozolomide empowers researchers to dissect DNA repair and chemotherapy resistance in glioma models, especially when ATRX status is a variable. This article delivers a stepwise workflow, advanced use-cases, and real-world troubleshooting, maximizing the unique properties of Temozolomide as a precision research tool.

• Fasudil (HA-1077) HCl: Precision ROCK Inhibition for Cancer

  2026-06-24

  Explore how Fasudil (HA-1077) HCl, a selective ROCK inhibitor, enables advanced interrogation of cell proliferation, migration, and apoptosis in cancer and lens models. This article provides unique mechanistic insights and assay guidance, bridging oncology and ophthalmology research.

16310 records 1/1088 page Next 12345 下5页 Last page